Abstract:The gastrointestinal epithelium serves as a selective barrier between the host immune system and the luminal antigens.Defects in this barrier function have been linked to many human diseases, including inflammatory bowel diseases (IBD).Claudin-1 (Cld-1) is an integral protein of the tight junction, the most apical cell-cell adhesion which also help regulate mucosal barrier properties.Recently, we demonstrated a key role of Cld-1 in dextran sodium sulfate (DSS)-induced colitis where mice overexpressing claudin-1 protein (Cld-1TG mice) in intestinal epithelium demonstrated severe colitis when subjected to DSS-drinking water.However, it remains unclear if defective mucosal healing supported persistent inflammation in these mice.To elucidate potential role of Cld-1 in repair/recovery from DSS insults, ageand sex-matched wild-type and Cld-1TG mice were fed 2.5% DSS for 7 days in drinking water to induce colitis.Thereafter, mice allowed to recover for colitis-associated injury for 10 days.The DSS-treated Cld-1TG mice showed a decrease in body weight as early as day-4 post DSS-administration (versus WT mice) and the trend continued until day-7.H & E showed remarkable epithelial damage in Cld-1TG mice and severe loss of the crypt structure than DSS-treated WT-mice.During the recovery phase, Cld-1TG mice showed hyperplastic elongated crypts with low grade dysplasia compared to the normal regenerative crypts in WT mice.Such an outcome not only confirmed deregulated mucosal healing in Cld-1TG mice but also potential susceptibility of these mice to colitis-associated cancer (CAC).We therefore examined potential role of Cld-1 in CAC.WT and Cld-1TG mice were subjected to the AOM/DSS-induced mouse model of CAC where Cld-1TG mice demonstrated significantly increase in colonic tumor growth and size.Histological examination revealed multiple adenomas and high level of dysplasia in Cld-1TG mice compared to the WT mice.Moreover, these pathogenic alterations correlated with a significant upregulation of β-catenin expression in AOM/DSS treated Cld-1TG mice colon (versus WT mice).Further analysis demonstrated significant increase in the nuclear accumulation of Ser-552 phosphorylated β-catenin (Ser-552) in Cld-1TG mice subjected to colitis and CAC than WT mice.Together these data indicate the potential role of Cld-1-/β-catenin signaling axis in the process of mucosal repair and carcinogenesis which may also increase susceptibility of IBD patients to CAC. Sa1808

Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.

P096 Characterization of suppressive immune cell subsets in mouse models of colitis-associated colorectal cancer

Immunopathogenesis of Colitis-Associated Cancer in an Animal Model.

The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer

Alpha-1 Antitrypsin Inhibits Tumorigenesis and Progression of Colitis-Associated Colon Cancer through Suppression of Inflammatory Neutrophil-Activated Serine Proteases and IGFBP-3 Proteolysis

F4/80+Ly6Chigh Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis

A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy

Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome

Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model

Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility

Matrix metalloproteinase 9 (MMP9) limits reactive oxygen species (ROS) accumulation and DNA damage in colitis-associated cancer

Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice

Crucial Involvement of Tumor-Associated Neutrophils in the Regulation of Chronic Colitis-Associated Carcinogenesis in Mice.

IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation

The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome

Faecalibacterium Prausnitzii Prevents Tumorigenesis in A Model of Colitis-Associated Colorectal Cancer

Intestinal Epithelial Cell Autophagy Deficiency Suppresses Inflammation-Associated Colon Tumorigenesis.

Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer

T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice